Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-27638

Single-particle
3.0 Å
EMD-27638
3D View Gallery
Deposition: 15/07/2022
Map released: 19/07/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27638
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8dpm summary report (pdf.gz) Map and 8dpm FULL report (pdf.gz)
EMICSS annotations (xml)

Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound

EMD-27638

Single-particle
3.0 Å
EMD-27638
3D View Gallery
Deposition: 15/07/2022
Map released: 19/07/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Ebola virus - Mayinga, Zaire, 1976, Homo sapiens, Mus musculus
Sample: Complex of Ebola virus glycoprotein trimer with 1A2 antibody Fab and 6D6 antibody scFv
Fitted models: 8dpm

Deposition Authors: Yu X, Saphire EO
The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus.
Yu X, Hastie KM, Davis CW, Avalos RD, Williams D, Parekh D, Hui S , Mann C, Hariharan C, Takada A, Ahmed R, Saphire EO
(2023) Cell Rep , 42 , 113366 - 113366
PUBMED: 37938974
DOI: doi:10.1016/j.celrep.2023.113366
ISSN: 2211-1247